Shueb, S. S., Erb, S. J., Lunzer, M. M., Speltz, R., Harding-Rose, C., Akgün, E., . . . Portoghese, P. S. (2019). Targeting MOR-mGluR(5) heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5. Neuropharmacology.

Shueb, Sarah S., Samuel J. Erb, Mary M. Lunzer, Rebecca Speltz, Catherine Harding-Rose, Eyup Akgün, Donald A. Simone, i Philip S. Portoghese. "Targeting MOR-mGluR(5) Heteromers Reduces Bone Cancer Pain By Activating MOR and Inhibiting MGluR5." Neuropharmacology 2019.

Shueb, Sarah S., et al. "Targeting MOR-mGluR(5) Heteromers Reduces Bone Cancer Pain By Activating MOR and Inhibiting MGluR5." Neuropharmacology 2019.